Crystal structure of Nsp15 endoribonuclease NendoU from SARS‐CoV ‐2

Citations Over TimeTop 1% of 2020 papers

Abstract

Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) is rapidly spreading around the world. There is no existing vaccine or proven drug to prevent infections and stop virus proliferation. Although this virus is similar to human and animal SARS-CoVs and Middle East Respiratory Syndrome coronavirus (MERS-CoVs), the detailed information about SARS-CoV-2 proteins structures and functions is urgently needed to rapidly develop effective vaccines, antibodies, and antivirals. We applied high-throughput protein production and structure determination pipeline at the Center for Structural Genomics of Infectious Diseases to produce SARS-CoV-2 proteins and structures. Here we report two high-resolution crystal structures of endoribonuclease Nsp15/NendoU. We compare these structures with previously reported homologs from SARS and MERS coronaviruses.

Related Papers

• → Amplicon and Metagenomic Analysis of Middle East Respiratory Syndrome (MERS) Coronavirus and the Microbiome in Patients with Severe MERS(2021)22 cited
• → Current status of treatment for 2019 novel coronavirus pneumonia(2020)2 cited
• → Circulation of Non-Middle East Respiratory Syndrome (MERS) Coronaviruses in Imported Camels in Saudi Arabia(2024)1 cited
• Middle East Respiratory Syndrome (MERS) - Facts(2014)
• → Risk and Prevention of Middle East Respiratory Syndrome (MERS)(2021)